LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...
The news: Hearing device maker Cochlear has received regulatory approval from the US Food and Drug Administration (FDA) for its new Nucleus Nexa System, and its Nucleus Kanso 3 and Kanso 3 Nexa sound ...
LONE TREE, Colo., Feb. 25, 2025 /PRNewswire/ — In celebration of International Cochlear Implant Day, Cochlear North America is thrilled to announce the winners of 2025 annual Cochlear Academic ...
Cochlear downgraded fiscal 2025 NPAT guidance by 6% at the midpoint to AUD 390 million-AUD 400 million. Services revenue declined more than expected and cochlear implant sales in developed markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results